selectION, Inc. Strengthens its Leadership and Scientific Team with the Appointment of Cam Gallagher to its Board of Directors & Dr. Christopher Larson, Ph.D. as Strategic Advisor and Member of the Scientific Advisory Board
SAN DIEGO, August 29, 2018 – selectION, Inc. a biotechnology company that has established an efficient technology platform to develop novel peptide therapies incorporating highly selective peptide blockers for ion…
Read More